Trailing-twelve-month (TTM) net income is $2.13 Billion with a year-over-year change of (60.35%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $1.05B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-14T21:25:40.998Z. Historical observations retain their original dates. Historical series through 2026-09-11.
$2.13B
$2.13 Billion
(60.35%)
vs. $5.38B a year ago (TTM)
(17.30%)
5 Year compound annual growth rate
1 Year
(60.35%)
3 Year
(11.66%)
5 Year
(17.30%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.81B | ($2.86B) | (50.46%) |
| 2024 | $5.66B | +$2.26B | +66.41% |
| 2023 | $3.40B | +$1.90B | +126.30% |
| 2022 | $1.50B | +$2.06B | N/A |
| 2021 | ($560.27M) | ($8.13B) | (107.40%) |
| 2020 |
TTM Growth
(60.35%)
3-Year CAGR
(11.66%)
5-Year CAGR
(17.30%)
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-14T21:25:40.998Z. Historical observations retain their original dates. Historical series through 2026-09-11.
| $7.57B |
| +$5.82B |
| +332.60% |
| 2019 | $1.75B | +$2.11B | N/A |
| 2018 | ($362.28M) | ($382.06M) | (1931.74%) |
| 2017 | $19.78M | +$307.84M | N/A |
| 2016 | ($288.06M) | +$902.63M | N/A |